Anavex Life Sciences reports blarcamesine study results in Parkinson's model

Go back to Anavex Life Sciences reports blarcamesine study results in Parkinson's model
Anavex Life Sciences Corp. (NASDAQ: AVXL) Delayed: 2.50 --0 (-0%)
Previous Close $2.50    52 Week High $8.30 
Open $2.50    52 Week Low $2.43 
Day High $2.58    P/E N/A 
Day Low $2.45    EPS $-0.22 
Volume 1,222,156